Effect of artemether on analgesia and inflammation in mice and rats
Abstract
Artemether, currently one of the first-line antimalarials in Nigeria was evaluated for its ability to reduce pain and inflammation, which are common symptoms of malaria. This study was to ascertain whether artemether has an analgesic / anti-inflammatory effect to complement its anti-parasitic activity against Plasmodium species. Acetic-acid-induced writhing test was used to measure peripheral-analgesic activity in mice while the tail-flick and hot-plate methods were used for central-analgesic activity. Fluid-volume-displacement by egg-albumin-induced hind-paw oedema in rats was used to assess for anti-inflammatory effect. Artemether was administered i.p., at three-doses equivalent to therapeutic-dose (1.5 mg/kg) as well as 5 and 10-times higher (7.5 and 15 mg/kg), once (acute) and daily for 7 days (sub-acute). Artemether inhibited peripheral-pain dose-dependently, but this was not significant at 1.5 mg/kg. Statistically significant pain-inhibition (P<0.05) greater than that due to dipyrone was provided only at the doses of 7.5 and 15 mg/kg artemether. Analgesic assessment using tail-flick and hot-plate methods did not show any detectable effect even at higher doses, indicating that any pain-relief due to artemether was not centrally-mediated. Artemether reduced the readiness / degree of fluid accumulation after an initial-transitory (30-60 minutes) increase in oedema, following albumin injection. These effects were similar to, but less than those of indomethacin. The data showed that artemether exhibited only mild peripheral analgesic and anti-inflammatory activities which may not be observable at therapeutic-doses and therefore may not, on its own contribute significantly to the relief of pain / inflammation in the treatment of malaria.
Keywords: Artemether; Analgesia; Inflammation; Mice; Rats
Journal of Pharmacy and Bioresources Vol. 4 (2) 2007: pp. 39-48
Copyright of articles published shall reside exclusively with the Faculty of Pharmaceutical Sciences, University of Jos.
DECLARATION & COPYRIGHT TRANSFER
I/We the undersigned author(s) of article entitled
…………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………
Declare as follows:
- The manuscript submitted to Journal of Pharmacy & Bioresources is original and has not been and will be published, whole or in part, in print or electronic format, in any other journal. It is also not being currently considered for publication in any journal.
- The submitted manuscript is a joint decision of all the coauthors.
- Each author has participated sufficiently in the work to warrant his or her inclusion in the list of authors. To this end, each author takes responsibility for appropriate portions of the manuscript.
- Authors have obtained necessary approval to carry out the experiments on animals and human subjects. Approval certificates will be furnished, if required by publishers or editors of the journal.
- Authors do not have any conflict of interest (financial or otherwise) other than those declared.
- If the manuscript is accepted for publication, the authors transfer and assign copyright of the article referenced above to Journal of Pharmacy and Bioresources.
Name & Signature of authors
1. 2.
- 4.
- 6.
- 8.
Corresponding authors name address, affiliation and email: